Teladoc Health (TDOC) EBIAT (2016 - 2025)
Teladoc Health (TDOC) has disclosed EBIAT for 12 consecutive years, with -$25.1 million as the latest value for Q4 2025.
- Quarterly EBIAT rose 48.06% to -$25.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$200.3 million through Dec 2025, up 79.99% year-over-year, with the annual reading at -$200.3 million for FY2025, 79.99% up from the prior year.
- EBIAT hit -$25.1 million in Q4 2025 for Teladoc Health, up from -$49.5 million in the prior quarter.
- In the past five years, EBIAT ranged from a high of -$11.0 million in Q4 2021 to a low of -$6.7 billion in Q1 2022.
- Historically, EBIAT has averaged -$775.5 million across 5 years, with a median of -$71.4 million in 2022.
- Biggest five-year swings in EBIAT: tumbled 34584.31% in 2022 and later soared 99.24% in 2023.
- Year by year, EBIAT stood at -$11.0 million in 2021, then crashed by 34584.31% to -$3.8 billion in 2022, then skyrocketed by 99.24% to -$28.9 million in 2023, then tumbled by 67.56% to -$48.4 million in 2024, then surged by 48.06% to -$25.1 million in 2025.
- Business Quant data shows EBIAT for TDOC at -$25.1 million in Q4 2025, -$49.5 million in Q3 2025, and -$32.7 million in Q2 2025.